SaaS · Healthcare
All Of Me Wellness Launches as a New Home for Women's Health
New platform brings vetted resources, real stories, and community together in one place.
Sep 1 · 23:58PRLog
6,584 press releases indexed under healthcare.
New platform brings vetted resources, real stories, and community together in one place.
Markham, ON, September 01, 2026--For months, 8 CUPE locals representing over 1100 long term care workers across Ontario have been kept waiting for a fair contract. Where other workers would have been able to go on strike to force the employer back to the table, these workers are denied that right under the Hospital Labour Disputes Arbitration Act (HLDAA), forcing them into a long and drawn-out process to get a fair contract.
MELBOURNE, Australia and INDIANAPOLIS, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announced completion of patient enrollment in the Phase 3 BiPASS™ study of its commercial PSMA-PET 1 imaging agents, Illuccix® (kit for the preparation of gallium Ga68 gozetotide injection) and Gozellix® (kit for the preparation of gallium Ga68 gozetotide injection) for prostate cancer imaging in the pre-biopsy setting. Telix has also aligned with the United States (U.S.) Food and Drug Administration (FDA) on a New Drug Application (NDA) pathway for BiPASS that, if approved, would support reimbursement as a new product and broaden patient access.
MIAMI, September 01, 2026--AIDS Healthcare Foundation (AHF), in collaboration with the University of Miami Public Health Policy Lab, will co-host a webinar, "Freedom from Debt: A Global Dialogue on Fiscal Space, Health, and Development," on Thursday, September 3, 2026, at 10:00 AM EDT, virtually via Zoom. Register here.
EAGLE, Idaho, Sept. 01, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it will participate in the upcoming 2026 Jefferies Healthcare Services Conference on September 15, 2026.
MONTREAL, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. ("Knight") (TSX: GUD), a pan-American (ex-US) pharmaceutical company, announced today that it has received regulatory approval from INVIMA, the Colombian health regulatory agency, for TAVALISSE ® (fostamatinib disodium hexahydrate) for the treatment of adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response, loss of response, or intolerance to prior treatment with corticosteroids and intravenous immunoglobulin. 1
MANHASSET, N.Y., September 01, 2026--Unlocking a crucial piece of schizophrenia’s molecular puzzle, scientists at Northwell Health’s Feinstein Institutes for Medical Research have found that jumping genes, also known as transposable elements, are linked to a communication breakdown in the blood gene expression networks of people living with schizophrenia. Jumping genes are DNA sequences from ancient viruses and other elements that could once move around the human genome – and in rare cases still
COLUMBIA, Md., Sept. 1, 2026 /PRNewswire/ -- A new national survey from MedStar Health suggests millions of men age 55 and older may be missing chances to get screened for prostate cancer, even though it is one of the most common cancers in men. Of surveyed men age 55 and older, 30% have...
GENEVA, SWITZERLAND - September 1, 2026 ( NEWMEDIAWIRE ) - MindMaze Therapeutics Holding SA (SIX: MMTX ) (MindMaze Therapeutics or the Company), a global leader in scalable precision neurotherapeutics, today announced its participation in several upcoming investor and industry conferences in the United States and Europe. Investor Conferences Conference: Baader Investment Conference Location: Munich, Germany Presentation: September 21, 2026 at 5:40 p.m. CET Conference: Global Markets Forum Location: New York, NY Presentation: October 7, 2026 Management will be available for one-on-one meetings. Investors interested in meeting with the Company are invited to contact ir@mindmazetherapeutics.com. Industry Conferences Conference: American Medical Rehabilitation Providers Association (AMRPA) Edu
SAN FRANCISCO, September 01, 2026--Paubox has made its HIPAA compliant forms callable by AI agents. An agent can pull a form's questions, collect a patient's answers in conversation, and submit the completed response into Paubox. The record lands under the same business associate agreement (BAA) that covers the rest of the platform.
SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment approach for ovarian cancer, today announced that on September 1, 2026, the Compensation Committee of Zentalis’ Board of Directors granted non-qualified stock options to purchase an aggregate of 269,000 shares of the Company’s common stock to four (4) newly hired employees. The stock options were granted under the Zentalis Pharmaceuticals, Inc. 2022 Employment Inducement Incentive Award Plan (2022 Inducement Plan) as an inducement material to each such individual’s entering into employment with Zentalis in accordance with Nasdaq Listing Rule 5
MOUNTAIN VIEW, Calif., September 01, 2026--NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will participate in the upcoming 2026 Cantor Global Healthcare Conference.